RankingsPricing
  1. JP-listed companies
  2. TAKARA BIO INC.
  3. Financials
  4. Stockholders' equity

TAKARA BIO INC.JP:4974

Market cap
¥94.8B
P/E ratio
-10.5x
SummaryFinancialsHistoryOwnershipWorkforce
Period EndStockholders' equity (Million JPY)YoY (%)
Mar 31, 2025115,849+3.64%
Mar 31, 2024111,784-0.60%
Mar 31, 2023112,454+17.06%
Mar 31, 202296,064+29.29%
Mar 31, 202174,302+11.58%
Mar 31, 202066,591+3.89%
Mar 31, 201964,095+3.45%
Mar 31, 201861,959+3.29%
Mar 31, 201759,985-0.21%
Mar 31, 201660,110+0.78%
Mar 31, 201559,642+4.40%
Mar 31, 201457,127

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)